The man, known only as Silvano, decided in a rare moment of consciousness to be recorded for future studies and to have his brain harvested for research in hopes of finding a cure for future victims. Ignazio Roiter received a patient at the University of Bologna hospital's sleep institute. In late 1983, Italian neurologist/sleep expert Dr. The tragic thing is, the symptoms don't show until after the child-bearing years are over (typically over 40 years), so parents usually pass on the defective gene without realizing. Because Fatal Familial Insomnia is genetic, there is a 50% chance of a parent passing it on to their offspring. This increasingly prevents the sufferer from losing consciousness - although their EEG readings show signs associated with REM sleep during waking hours: they are so sleep deprived, they are dreaming while awake. In FFI, prions eat away the thalamus region of the brain, responsible for regulating sleep and various sensory and motor systems. Prions are responsible for the outbreak of Bovine Spongiform Encephalopathy (BSE) in cattle and Creutzfeldt - Jakob disease (CJD) in humans. Specifically, a prion is a mis-folded protein that permanently affects the structure of the brain. The term prionwas coined by Stanley Prusiner in the 1980s as the name for an infectious agent. We now know that Fatal Familial Insomnia is a prion disease. Finally, as the peculiar features of FFI indicate that the disease process originates in the thalamus, spreading later to the cortex, the participants aim at resolving some pathogenetic aspects of the disease by tracing the neural pathways leading to and from the AV and MD thalamic nuclei in the experimental animal (by means of lesioning brain studies in the cat), in order to check whether the neural circuitry connecting these 2 thalamic nuclei may compare with the pathological changes observed in the autopsy cases of FFI.The symptoms of Fatal Familial Insomnia are as follows Therefore, all patients will be genetically characterised also in regard of the 129 polymorphism on the wild-type PRNP allele, in order to check for a possible cause of phenotypic variability in the disease. Preliminary clinical data suggest that the 129 codon polymorphism on the non-mutated allele may also have some influence in the clinical expression of the disease, in particular disease duration. By definition, all FFI patients show the 178 codon mutation in the PRNP associated with the met polymorphism at codon 129 of the mutated allele.
Fatal familial insomnia cases full#
Once the full phenotypic characterisation of FFI be achieved, the second objective shall be that of correlating clinical features and neuropathological changes to genetic background. Possible phenotypic variability will also be detected and the full spectrum of disease described by this method. Accordingly, all the relevant clinical, laboratory and neuropathological features, when available, will be subjected to a detailed and quantified scrutiny in relation to the disease course.
Fatal familial insomnia cases series#
The participants aim at defining the clinical and pathological features of such a disease by pooling all together the cases observed in France and in Italy (a total of 5 families) which have undergone a series of uniform investigations, in order to minimise the interfamilial variability and to establish a common definition of the disease and set certain diagnostic criteria. The disease is pathologically characterised by neuronal loss and gliosis in the MD and AV thalamic nuclei, and variable neuronal degeneration and spongiosis in the cerebral, especially frontal, temporal and parietal, and cerebellar cortex.
FFI is a rare hereditary disorder clinically characterised by early and intractable loss of sleep (insomnia), prominent autonomic activation with tachycardia, hypertension, diaphoresis, pyrexia and sphyncter loss, and motor impairment (ataxia, dysarthria, myoclonus, pyramidal signs). To describe in the experimental animal the neural circuitry connecting the MD and AV thalamic nuclei to the cerebral cortex and other subcortical regions, in order to characterise neural pathways possibly relevant to the spread of prions. To correlate the spectrum of clinico-pathological features to the genetic background, in particular the codon 129 polymorphism in the PRNP. To characterise in detail the clinical, laboratory and neuropathological features of Fatal Familial Insomnia (FFI), a rare hereditary human prion encephalopathy with a 178 codon mutation in the prion protein gene (PRNP) leading to prominent degeneration of the anteroventral (AV) and dorsomedian (DM) thalamic nuclei.
0 kommentar(er)
